1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Skjeldal, L. Peterson, F.C. Doreleijers, J.F. Moe, L.A. Pikus, J.D. Volkman, B.F. Westler, W.M. Markley, J.L. Fox, B.G. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking Fe2 S2 175.820 FE2/S2 (INORGANIC) CLUSTER non-polymer C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking GW J.Biol.Inorg.Chem. JJBCFA 2154 0949-8257 9 945 953 10.1007/s00775-004-0594-4 15452777 Solution structure of T4moC, the Rieske ferredoxin component of the toluene 4-monooxygenase complex 2004 US Biochemistry BICHAW 0033 0006-2960 35 9106 9119 10.1021/bi960456m 8703915 Recombinant toluene-4-monooxygenase: catalytic and Mossbauer studies of the purified diiron and rieske components of a four-protein complex 1996 US Biochemistry BICHAW 0033 0006-2960 38 727 739 10.1021/bi981851a 9888813 Detection and classification of hyperfine-shifted 1H, 2H, and 15N resonances of the Rieske ferredoxin component from toluene 4-monooxygenase 1999 US Protein Expr.Purif. PEXPEJ 0757 1046-5928 16 109 119 10.1006/prep.1999.1067 10336868 Application of fed-batch fermentation to the preparation of isotopically labeled or selenomethionyl-labeled proteins 1999 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 12336.695 Toluene-4-monooxygenase system protein C 1 man polymer 175.820 FE2/S2 (INORGANIC) CLUSTER 1 syn non-polymer T4MOC no no MSFEKICSLDDIWVGEMETFETSDGTEVLIVNSEEHGVKAYQAMCPHQEILLSEGSYEGGVITCRAHLWTFNDGTGHGIN PDDCCLAEYPVEVKGDDIYVSTKGILPNKAHS MSFEKICSLDDIWVGEMETFETSDGTEVLIVNSEEHGVKAYQAMCPHQEILLSEGSYEGGVITCRAHLWTFNDGTGHGIN PDDCCLAEYPVEVKGDDIYVSTKGILPNKAHS A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Pseudomonas KR1 Escherichia Escherichia coli sample TMOC 300 Pseudomonas mendocina 469008 Escherichia coli BL21(DE3) BL21 (DE3) plasmid pJP01 repository Initial release Version format compliance Version format compliance 1 0 2004-09-07 1 1 2008-04-29 1 2 2011-07-13 BphF, Rieske ferredoxin of biphenyl dioxygenase RCSB Y RCSB 2004-03-03 REL REL FES FE2/S2 (INORGANIC) CLUSTER target function 100 20 2D NOESY 2D TOCSY HNCA-J 3D_13C-separated_NOESY 3D_15N-separated_NOESY 20 mM phosphate 6.4 ambient 298 K simulated annealing 1 closest to the average 20 mM phosphate, 90% H2O, 10% D2O 90% H2O/10% D2O Molecular Simulations, Inc collection FELIX 95 Hermann processing CANDID 1 Gntert refinement CYANA 1 Schwieters structure solution XPLOR-NIH 1 Cornilescu refinement TALOS 1 600 Bruker DMX FES 113 2 FES FES 113 A MET 1 n 1 MET 1 A SER 2 n 2 SER 2 A PHE 3 n 3 PHE 3 A GLU 4 n 4 GLU 4 A LYS 5 n 5 LYS 5 A ILE 6 n 6 ILE 6 A CYS 7 n 7 CYS 7 A SER 8 n 8 SER 8 A LEU 9 n 9 LEU 9 A ASP 10 n 10 ASP 10 A ASP 11 n 11 ASP 11 A ILE 12 n 12 ILE 12 A TRP 13 n 13 TRP 13 A VAL 14 n 14 VAL 14 A GLY 15 n 15 GLY 15 A GLU 16 n 16 GLU 16 A MET 17 n 17 MET 17 A GLU 18 n 18 GLU 18 A THR 19 n 19 THR 19 A PHE 20 n 20 PHE 20 A GLU 21 n 21 GLU 21 A THR 22 n 22 THR 22 A SER 23 n 23 SER 23 A ASP 24 n 24 ASP 24 A GLY 25 n 25 GLY 25 A THR 26 n 26 THR 26 A GLU 27 n 27 GLU 27 A VAL 28 n 28 VAL 28 A LEU 29 n 29 LEU 29 A ILE 30 n 30 ILE 30 A VAL 31 n 31 VAL 31 A ASN 32 n 32 ASN 32 A SER 33 n 33 SER 33 A GLU 34 n 34 GLU 34 A GLU 35 n 35 GLU 35 A HIS 36 n 36 HIS 36 A GLY 37 n 37 GLY 37 A VAL 38 n 38 VAL 38 A LYS 39 n 39 LYS 39 A ALA 40 n 40 ALA 40 A TYR 41 n 41 TYR 41 A GLN 42 n 42 GLN 42 A ALA 43 n 43 ALA 43 A MET 44 n 44 MET 44 A CYS 45 n 45 CYS 45 A PRO 46 n 46 PRO 46 A HIS 47 n 47 HIS 47 A GLN 48 n 48 GLN 48 A GLU 49 n 49 GLU 49 A ILE 50 n 50 ILE 50 A LEU 51 n 51 LEU 51 A LEU 52 n 52 LEU 52 A SER 53 n 53 SER 53 A GLU 54 n 54 GLU 54 A GLY 55 n 55 GLY 55 A SER 56 n 56 SER 56 A TYR 57 n 57 TYR 57 A GLU 58 n 58 GLU 58 A GLY 59 n 59 GLY 59 A GLY 60 n 60 GLY 60 A VAL 61 n 61 VAL 61 A ILE 62 n 62 ILE 62 A THR 63 n 63 THR 63 A CYS 64 n 64 CYS 64 A ARG 65 n 65 ARG 65 A ALA 66 n 66 ALA 66 A HIS 67 n 67 HIS 67 A LEU 68 n 68 LEU 68 A TRP 69 n 69 TRP 69 A THR 70 n 70 THR 70 A PHE 71 n 71 PHE 71 A ASN 72 n 72 ASN 72 A ASP 73 n 73 ASP 73 A GLY 74 n 74 GLY 74 A THR 75 n 75 THR 75 A GLY 76 n 76 GLY 76 A HIS 77 n 77 HIS 77 A GLY 78 n 78 GLY 78 A ILE 79 n 79 ILE 79 A ASN 80 n 80 ASN 80 A PRO 81 n 81 PRO 81 A ASP 82 n 82 ASP 82 A ASP 83 n 83 ASP 83 A CYS 84 n 84 CYS 84 A CYS 85 n 85 CYS 85 A LEU 86 n 86 LEU 86 A ALA 87 n 87 ALA 87 A GLU 88 n 88 GLU 88 A TYR 89 n 89 TYR 89 A PRO 90 n 90 PRO 90 A VAL 91 n 91 VAL 91 A GLU 92 n 92 GLU 92 A VAL 93 n 93 VAL 93 A LYS 94 n 94 LYS 94 A GLY 95 n 95 GLY 95 A ASP 96 n 96 ASP 96 A ASP 97 n 97 ASP 97 A ILE 98 n 98 ILE 98 A TYR 99 n 99 TYR 99 A VAL 100 n 100 VAL 100 A SER 101 n 101 SER 101 A THR 102 n 102 THR 102 A LYS 103 n 103 LYS 103 A GLY 104 n 104 GLY 104 A ILE 105 n 105 ILE 105 A LEU 106 n 106 LEU 106 A PRO 107 n 107 PRO 107 A ASN 108 n 108 ASN 108 A LYS 109 n 109 LYS 109 A ALA 110 n 110 ALA 110 A HIS 111 n 111 HIS 111 A SER 112 n 112 SER 112 A author_defined_assembly 1 monomeric A HIS 47 A ND1 HIS 47 1_555 A FES 113 B FE2 FES 1_555 A FES 113 B S1 FES 1_555 110.9 A HIS 47 A ND1 HIS 47 1_555 A FES 113 B FE2 FES 1_555 A FES 113 B S2 FES 1_555 110.6 A FES 113 B S1 FES 1_555 A FES 113 B FE2 FES 1_555 A FES 113 B S2 FES 1_555 106.2 A HIS 47 A ND1 HIS 47 1_555 A FES 113 B FE2 FES 1_555 A HIS 67 A ND1 HIS 67 1_555 112.8 A FES 113 B S1 FES 1_555 A FES 113 B FE2 FES 1_555 A HIS 67 A ND1 HIS 67 1_555 107.6 A FES 113 B S2 FES 1_555 A FES 113 B FE2 FES 1_555 A HIS 67 A ND1 HIS 67 1_555 108.6 A CYS 45 A SG CYS 45 1_555 A FES 113 B FE1 FES 1_555 A FES 113 B S1 FES 1_555 111.4 A CYS 45 A SG CYS 45 1_555 A FES 113 B FE1 FES 1_555 A FES 113 B S2 FES 1_555 111.1 A FES 113 B S1 FES 1_555 A FES 113 B FE1 FES 1_555 A FES 113 B S2 FES 1_555 108.8 A CYS 45 A SG CYS 45 1_555 A FES 113 B FE1 FES 1_555 A CYS 64 A SG CYS 64 1_555 114.5 A FES 113 B S1 FES 1_555 A FES 113 B FE1 FES 1_555 A CYS 64 A SG CYS 64 1_555 104.5 A FES 113 B S2 FES 1_555 A FES 113 B FE1 FES 1_555 A CYS 64 A SG CYS 64 1_555 106.2 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N GLU 4 A N GLU 4 A O VAL 100 A O VAL 100 A O TYR 99 A O TYR 99 A N GLU 92 A N GLU 92 A N PHE 20 A N PHE 20 A O VAL 28 A O VAL 28 A N LEU 29 A N LEU 29 A O TYR 41 A O TYR 41 A N ALA 40 A N ALA 40 A O TYR 89 A O TYR 89 A N GLU 58 A N GLU 58 A O VAL 61 A O VAL 61 A N ILE 62 A N ILE 62 A O PHE 71 A O PHE 71 A N ASN 72 A N ASN 72 A O HIS 77 A O HIS 77 1 A A O H LEU THR 68 70 1.58 1 A A H3 OE1 MET GLU 1 4 1.58 3 A A HZ2 OD1 LYS ASP 5 97 1.58 5 A A HZ1 OD1 LYS ASP 5 97 1.58 7 A A HZ1 OE1 LYS GLU 39 88 1.60 12 A A HD1 OD2 HIS ASP 36 73 1.59 14 A A O FE2 ARG FES 65 113 2.19 16 A A OE1 HZ1 GLU LYS 92 94 1.56 17 A A OE2 HG GLU SER 18 53 1.59 18 A A OE2 HG GLU SER 18 53 1.59 20 A A HE2 OD2 HIS ASP 47 83 1.59 14 8.20 1.10 114.20 122.40 A A A CA CB SG CYS CYS CYS 45 45 45 N 14 13.19 1.20 111.50 124.69 A A A CB CA C CYS CYS CYS 64 64 64 N 14 9.80 1.10 114.20 124.00 A A A CA CB SG CYS CYS CYS 64 64 64 N 14 15.83 2.50 121.70 137.53 A A A C N CA CYS ARG ARG 64 65 65 Y 14 12.67 1.70 113.60 126.27 A A A CA CB CG HIS HIS HIS 67 67 67 N 14 A A CB SG CYS CYS 45 45 0.122 0.017 1.818 1.940 N 14 A A CA CB CYS CYS 64 64 0.239 0.022 1.535 1.774 N 14 A A CB SG CYS CYS 64 64 0.164 0.017 1.818 1.982 N 14 A A CA C CYS CYS 64 64 0.264 0.026 1.525 1.789 N 14 A A N CA ARG ARG 65 65 0.193 0.020 1.459 1.652 N 1 A PRO 46 -50.06 105.44 1 A TRP 69 35.94 -31.91 1 A ASN 80 -160.68 113.96 1 A ALA 110 178.24 -63.78 1 A HIS 111 56.23 -164.95 2 A PHE 3 58.28 97.97 2 A PRO 46 -78.47 42.25 2 A HIS 47 -96.26 -67.00 2 A GLN 48 -161.70 -35.62 2 A LEU 51 -89.26 41.85 2 A CYS 64 -63.85 -72.11 2 A ARG 65 161.05 104.85 2 A LEU 68 58.15 82.74 2 A THR 75 -148.78 -47.98 2 A ASP 96 72.23 -6.40 2 A LYS 109 64.10 -53.32 2 A ALA 110 -86.59 -156.80 3 A PHE 3 68.70 103.41 3 A PRO 46 -1.44 42.50 3 A GLN 48 68.31 123.70 3 A SER 56 -130.76 -73.29 3 A LEU 68 -157.56 -95.25 3 A TRP 69 172.96 -16.46 3 A LYS 109 49.66 -87.46 3 A ALA 110 44.99 -156.95 3 A HIS 111 69.22 116.33 4 A SER 2 -148.70 -145.93 4 A CYS 7 -171.98 -173.79 4 A CYS 45 -159.25 85.57 4 A GLU 49 -52.16 100.05 4 A ILE 50 63.75 -79.84 4 A ARG 65 46.39 80.95 4 A ALA 66 174.02 -45.40 4 A TRP 69 -96.71 -69.45 4 A ASP 96 78.92 -19.53 4 A HIS 111 -64.31 97.98 5 A SER 2 60.63 -87.95 5 A GLN 48 -140.95 -63.89 5 A ILE 50 -108.42 -161.57 5 A ARG 65 -49.82 107.00 5 A LEU 68 64.95 -170.34 5 A THR 75 -151.40 -38.62 5 A ASN 80 159.34 105.49 5 A LYS 109 57.00 -169.16 5 A ALA 110 65.40 -167.53 5 A HIS 111 74.12 116.09 6 A SER 2 -159.13 -60.49 6 A PRO 46 -76.15 21.78 6 A GLN 48 60.11 -172.11 6 A GLU 49 -161.66 -48.88 6 A LEU 51 79.67 -25.88 6 A SER 56 178.28 -53.67 6 A ASP 82 164.91 -35.06 7 A SER 2 55.77 91.42 7 A PHE 3 74.17 96.77 7 A PRO 46 -69.58 24.31 7 A GLN 48 63.33 108.14 7 A ARG 65 64.47 -80.93 7 A HIS 67 84.01 97.24 7 A LEU 68 -149.51 -80.04 7 A ASN 80 77.28 115.06 7 A ASP 82 -68.99 2.76 7 A LYS 109 58.88 178.87 7 A ALA 110 65.60 -78.10 8 A PHE 3 68.54 84.79 8 A MET 44 62.73 -100.21 8 A CYS 45 49.56 96.36 8 A PRO 46 -75.58 36.96 8 A GLN 48 62.78 142.33 8 A ILE 50 169.83 167.18 8 A ARG 65 169.24 -48.57 8 A ALA 66 -147.69 -87.41 8 A HIS 67 52.87 -85.74 8 A LEU 68 -174.16 -60.66 8 A THR 75 -152.95 -44.83 8 A ASP 82 152.54 -36.42 8 A LYS 109 52.43 -76.09 8 A HIS 111 61.02 92.38 9 A ALA 43 -106.86 -78.17 9 A MET 44 53.26 -84.29 9 A CYS 45 55.49 84.77 9 A HIS 47 -103.68 -78.60 9 A GLU 49 69.42 -89.42 9 A ILE 50 58.24 -81.68 9 A LEU 51 -167.03 92.06 9 A HIS 67 -167.94 -76.37 9 A ASN 80 -164.24 110.79 9 A ASP 96 84.86 -33.46 9 A ALA 110 -176.13 -38.64 10 A PHE 3 72.46 93.53 10 A GLN 48 178.57 110.56 10 A SER 56 -143.26 -33.76 10 A ALA 66 62.80 100.18 10 A LEU 68 171.36 -63.26 10 A TRP 69 -141.05 -155.57 10 A ASN 80 -160.73 108.47 10 A ASP 83 38.76 31.53 10 A CYS 84 79.13 148.60 10 A LYS 103 -58.47 -76.31 10 A HIS 111 56.42 -91.06 11 A PRO 46 -82.07 31.41 11 A HIS 47 -120.34 -75.34 11 A SER 56 -161.41 -25.02 11 A ARG 65 75.93 -21.87 11 A LEU 68 36.94 -107.21 11 A TRP 69 -163.70 -51.36 11 A LYS 109 50.30 -176.89 11 A ALA 110 57.53 -82.35 12 A PHE 3 73.54 108.21 12 A HIS 47 -88.74 -96.90 12 A GLN 48 -179.30 104.59 12 A GLU 49 -171.97 145.80 12 A SER 56 -173.49 146.89 12 A ALA 66 -83.08 -72.32 13 A SER 2 59.24 84.76 13 A PHE 3 67.22 100.25 13 A ILE 50 -179.99 -156.51 13 A CYS 64 -81.33 -72.71 13 A ARG 65 -149.02 -63.42 13 A HIS 67 162.32 -29.59 13 A LEU 68 172.59 -71.70 13 A TRP 69 -176.92 -49.97 13 A THR 75 -155.33 -51.28 13 A LYS 109 -62.42 93.91 13 A ALA 110 174.44 -149.46 13 A HIS 111 51.66 88.15 14 A ALA 43 -141.17 19.12 14 A ILE 50 -152.74 -159.50 14 A SER 56 -107.14 -80.39 14 A CYS 64 -118.32 -112.49 14 A ARG 65 -122.29 -161.89 14 A ALA 66 -55.95 100.38 14 A TRP 69 -146.32 -159.96 14 A HIS 111 75.91 -36.52 15 A SER 2 67.01 -69.70 15 A HIS 47 -64.77 -86.14 15 A ILE 50 -156.74 24.93 15 A LEU 51 69.31 84.38 15 A SER 56 -157.27 -62.02 15 A CYS 64 -76.29 -85.44 15 A ARG 65 -178.81 -34.75 15 A LEU 68 -53.41 -70.61 15 A TRP 69 -129.18 -93.71 15 A THR 75 -163.46 -45.34 15 A ALA 87 46.30 102.46 15 A LYS 109 67.72 160.93 15 A ALA 110 74.03 -67.92 16 A SER 2 78.65 -44.81 16 A ALA 43 -102.46 78.70 16 A CYS 45 -170.87 90.67 16 A GLN 48 -138.00 -72.02 16 A CYS 64 -69.92 -155.20 16 A LEU 68 73.21 -48.69 16 A ASP 82 90.14 -39.35 16 A LYS 109 -52.81 104.60 16 A ALA 110 175.00 -30.64 17 A SER 2 60.33 -80.38 17 A MET 44 -66.07 94.10 17 A CYS 45 -166.47 93.84 17 A PRO 46 -86.98 30.27 17 A GLU 49 -92.55 -62.43 17 A SER 56 -138.53 -77.86 17 A CYS 64 -156.21 34.70 17 A ARG 65 72.32 -22.91 17 A ALA 66 71.17 100.84 17 A LEU 68 -147.55 -55.10 17 A TRP 69 -170.62 -143.78 17 A THR 75 -139.85 -46.64 17 A ALA 110 -174.17 103.16 17 A HIS 111 77.98 -70.59 18 A SER 2 178.57 133.78 18 A PHE 3 52.46 87.82 18 A MET 44 64.07 179.42 18 A PRO 46 -85.80 37.26 18 A LEU 51 60.61 69.49 18 A SER 56 -125.31 -57.68 18 A ALA 66 69.05 -38.34 18 A LEU 68 49.24 -97.49 18 A TRP 69 -166.98 -44.74 19 A SER 2 58.08 -161.25 19 A GLN 48 47.90 -102.98 19 A GLU 49 58.50 -75.49 19 A ARG 65 71.76 -36.28 19 A LEU 68 179.87 -77.53 19 A TRP 69 177.32 -27.69 19 A CYS 85 -145.39 -79.42 19 A LYS 109 -49.23 -14.74 19 A HIS 111 66.54 74.76 20 A SER 2 -162.17 -163.98 20 A PHE 3 -59.54 102.88 20 A CYS 7 -162.30 -166.58 20 A PRO 46 -85.07 39.05 20 A HIS 47 -102.25 -77.03 20 A GLN 48 -170.15 131.78 20 A GLU 49 64.54 86.44 20 A LEU 51 -154.38 48.92 20 A CYS 64 -78.09 -73.86 20 A ARG 65 174.72 -69.23 20 A THR 75 -156.70 -44.20 20 A ASP 96 76.27 -13.82 20 A LYS 109 -56.10 106.01 20 A ALA 110 174.52 -69.86 20 A HIS 111 39.29 -90.65 Toluene-4-monooxygenase system protein C Solution Structure of T4moC, the Rieske Ferredoxin Component of the Toluene 4-Monooxygenase Complex 1 N N 2 N N A LEU 51 A LEU 51 HELX_P A GLY 55 A GLY 55 5 1 5 metalc 2.131 A HIS 47 A ND1 HIS 47 1_555 A FES 113 B FE2 FES 1_555 metalc 2.123 A HIS 67 A ND1 HIS 67 1_555 A FES 113 B FE2 FES 1_555 metalc 2.322 A CYS 45 A SG CYS 45 1_555 A FES 113 B FE1 FES 1_555 metalc 2.242 A CYS 64 A SG CYS 64 1_555 A FES 113 B FE1 FES 1_555 ELECTRON TRANSPORT Rieske [2Fe-2S] domain, ferredoxin, Pfam PF00355, ELECTRON TRANSPORT A ASN 80 A ASN 80 1 A PRO 81 A PRO 81 4.35 A ASN 80 A ASN 80 2 A PRO 81 A PRO 81 -1.02 A ASN 80 A ASN 80 3 A PRO 81 A PRO 81 3.31 A ASN 80 A ASN 80 4 A PRO 81 A PRO 81 -0.52 A ASN 80 A ASN 80 5 A PRO 81 A PRO 81 1.04 A ASN 80 A ASN 80 6 A PRO 81 A PRO 81 0.38 A ASN 80 A ASN 80 7 A PRO 81 A PRO 81 -0.14 A ASN 80 A ASN 80 8 A PRO 81 A PRO 81 -4.36 A ASN 80 A ASN 80 9 A PRO 81 A PRO 81 1.06 A ASN 80 A ASN 80 10 A PRO 81 A PRO 81 -3.05 A ASN 80 A ASN 80 11 A PRO 81 A PRO 81 -4.47 A ASN 80 A ASN 80 12 A PRO 81 A PRO 81 -1.09 A ASN 80 A ASN 80 13 A PRO 81 A PRO 81 -3.91 A ASN 80 A ASN 80 14 A PRO 81 A PRO 81 0.22 A ASN 80 A ASN 80 15 A PRO 81 A PRO 81 -3.99 A ASN 80 A ASN 80 16 A PRO 81 A PRO 81 -0.87 A ASN 80 A ASN 80 17 A PRO 81 A PRO 81 -2.32 A ASN 80 A ASN 80 18 A PRO 81 A PRO 81 -1.32 A ASN 80 A ASN 80 19 A PRO 81 A PRO 81 -2.39 A ASN 80 A ASN 80 20 A PRO 81 A PRO 81 0.11 TMOC_PSEME UNP 1 0 Q00458 MSFEKICSLDDIWVGEMETFETSDGTEVLIVNSEEHGVKAYQAMCPHQEILLSEGSYEGGVITCRAHLWTFNDGTGHGIN PDDCCLAEYPVEVKGDDIYVSTKGILPNKAHS 0 111 1SJG 1 112 Q00458 A 1 1 112 3 4 4 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A PHE 3 A PHE 3 A SER 8 A SER 8 A ASP 97 A ASP 97 A SER 101 A SER 101 A VAL 91 A VAL 91 A LYS 94 A LYS 94 A GLU 16 A GLU 16 A GLU 21 A GLU 21 A GLU 27 A GLU 27 A ASN 32 A ASN 32 A VAL 38 A VAL 38 A GLN 42 A GLN 42 A GLU 88 A GLU 88 A TYR 89 A TYR 89 A TYR 57 A TYR 57 A GLU 58 A GLU 58 A VAL 61 A VAL 61 A THR 63 A THR 63 A THR 70 A THR 70 A ASN 72 A ASN 72 A HIS 77 A HIS 77 A GLY 78 A GLY 78 BINDING SITE FOR RESIDUE FES A 113 Software 8 A CYS 45 A CYS 45 8 1_555 A PRO 46 A PRO 46 8 1_555 A HIS 47 A HIS 47 8 1_555 A CYS 64 A CYS 64 8 1_555 A ARG 65 A ARG 65 8 1_555 A ALA 66 A ALA 66 8 1_555 A HIS 67 A HIS 67 8 1_555 A CYS 84 A CYS 84 8 1_555 1 P 1